Skip to content

Calumet, Inc. CLMT Derivatives

Derivatives at other companies

Par Pacific Holdings, Inc. logo
Par Pacific Holdings, Inc.PARR
Delek US Holdings logo
Delek US HoldingsDK

Other financials

Income statement

See full
Revenue$1.0B+3.6%
Gross profit-$87.5M-7.5%
Operating income-$171.3M-252%
Net income-$317.0M-95.7%
EPS (diluted)-$3.64-94.7%

Balance sheet

See full
Cash & equivalents$138.6M+12.3%
Total debt$2.3B-9.0%
Total equity-$1.0B-21.0%
Total assets$2.8B-2.4%

Cash flow

See full
Operating cash flow-$86.2M-194%
CapEx$13.2M-25.0%
Free cash flow-$99.4M-112%

Valuation

See full
Market cap$2.86B+185%
Enterprise value$5.06B+50.3%
P/S0.7×+0.4×

Profitability

See full
Gross margin5.8%+4.1pp
Operating margin4.8%
Net margin-4.5%-1.4pp
FCF margin0.1%

Returns & leverage

See full
Return on equity19.8%
Debt / equity-2.2×
Current ratio-0.1×

Where this comes from

Reported directly by Calumet, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DerivativeAssetsCurrent.

The official record: Calumet, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Calumet, Inc.'s derivatives.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Calumet, Inc.'s derivatives?
Calumet, Inc. (CLMT) reported derivatives of $6.7M in Q4 2025.